December 26, 2014
Topotarget confirms receipt of acceptance-to-file milestone payment
Media
December 25, 2014
Top-line data from a Phase 3 clinical trial demonstrates that Zubsolv® is as effective as Suboxone® film in the treatment of opioid dependence
December 24, 2014
Ultragenyx Announces Results from Phase 1/2 Study of KRN23 in X-linked Hypophosphatemia in Adults
December 24, 2014
HealthCap awarded SVCA’s Deal of the Year
December 21, 2014
Nordic Nanovector´s Betalutin™ granted Orphan-drug Designation
December 20, 2014
Orexo announces new partner for the commercialization of Zubsolv® in the United States.
December 19, 2014
Pulmonx Names New Chief Executive Officer
December 18, 2014
Nordic Nanovector announces successful closing of NOK 250 million pre-IPO private placement.
December 17, 2014
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways
December 17, 2014
Five Prime Therapeutics Announces Closing of Public Offering